StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Kiora Pharmaceuticals's operating margin for the twelve months ending Mar 31, 2025 was -55210.8%. For fiscal 2024 it was 28.2%, against -56960.5% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 202428.2%+56988.7
FY2020Dec 31, 2020-56960.5%−56304.3
FY2018Dec 31, 2018-656.3%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2024Jun 30, 2024-12724.4%−11714.0
Q1 FY2024Mar 31, 202482.6%+1238.9
Q4 FY2020Dec 31, 2020-9698.8%−9481.7
Q1 FY2019Mar 31, 201930.9%+5573.5
Q3 FY2018Sep 30, 2018-1010.5%+1233.0
Q2 FY2018Jun 30, 2018-1156.3%+425.9
Q1 FY2018Mar 31, 2018-217.1%+1014.1
Q3 FY2017Sep 30, 2017-5542.6%–
Q2 FY2017Jun 30, 2017-2243.4%–
Q1 FY2017Mar 31, 2017-1582.2%–
Q3 FY2016Sep 30, 2016-1231.2%–

More Kiora Pharmaceuticals figures

See a number that looks wrong?